Surrozen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Surrozen and other ETFs, options, and stocks.About SRZN
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.
CEOCraig C. Parker
CEOCraig C. Parker
Employees41
Employees41
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees41
Employees41
SRZN Key Statistics
Market cap211.63M
Market cap211.63M
Price-Earnings ratio-1.13
Price-Earnings ratio-1.13
Dividend yield—
Dividend yield—
Average volume144.54K
Average volume144.54K
High today$24.94
High today$24.94
Low today$23.72
Low today$23.72
Open price$23.72
Open price$23.72
Volume104.59K
Volume104.59K
52 Week high$24.94
52 Week high$24.94
52 Week low$5.90
52 Week low$5.90
Stock Snapshot
The current Surrozen(SRZN) stock price is $24.59, with a market capitalization of 211.63M. The stock trades at a price-to-earnings (P/E) ratio of -1.13.
On 2025-12-14, Surrozen(SRZN) stock traded between a low of $23.72 and a high of $24.94. Shares are currently priced at $24.59, which is +3.7% above the low and -1.4% below the high.
The Surrozen(SRZN)'s current trading volume is 104.59K, compared to an average daily volume of 144.54K.
In the last year, Surrozen(SRZN) shares hit a 52-week high of $24.94 and a 52-week low of $5.90.
In the last year, Surrozen(SRZN) shares hit a 52-week high of $24.94 and a 52-week low of $5.90.
People also own
Based on the portfolios of people who own SRZN. This list is generated using Robinhood data, and it’s not a recommendation.